Sprague D, Rohr C, Marchant J
Front Parasitol. 2025; 3():1349623.
PMID: 39817176
PMC: 11731825.
DOI: 10.3389/fpara.2024.1349623.
Chulkov E, Rohr C, Marchant J
Front Parasitol. 2025; 2():1285177.
PMID: 39816816
PMC: 11732042.
DOI: 10.3389/fpara.2023.1285177.
Dewi D, Irawati Tjahjo Widuri L, Allatib A, Athallah A, Balga A, Arkania N
Cureus. 2024; 16(7):e64617.
PMID: 39149676
PMC: 11324961.
DOI: 10.7759/cureus.64617.
Mian M, Sharmin D, Mondal P, Belayet J, Hossain M, McCusker P
Antimicrob Agents Chemother. 2024; 68(9):e0036924.
PMID: 39136467
PMC: 11373208.
DOI: 10.1128/aac.00369-24.
Marchant J
PLoS Negl Trop Dis. 2024; 18(2):e0011929.
PMID: 38358948
PMC: 10868838.
DOI: 10.1371/journal.pntd.0011929.
Development of non-sedating antischistosomal benzodiazepines.
Mian M, Sharmin D, Mondal P, Belayet J, Hossain M, McCusker P
bioRxiv. 2024; .
PMID: 38352313
PMC: 10862742.
DOI: 10.1101/2024.01.26.577323.
Mechanism of praziquantel action at a parasitic flatworm ion channel.
Park S, Friedrich L, Yahya N, Rohr C, Chulkov E, Maillard D
Sci Transl Med. 2021; 13(625):eabj5832.
PMID: 34936384
PMC: 8855674.
DOI: 10.1126/scitranslmed.abj5832.
Genetic analysis of praziquantel response in schistosome parasites implicates a transient receptor potential channel.
Le Clech W, Chevalier F, Mattos A, Strickland A, Diaz R, McDew-White M
Sci Transl Med. 2021; 13(625):eabj9114.
PMID: 34936381
PMC: 9491494.
DOI: 10.1126/scitranslmed.abj9114.
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?.
Pfab C, Schnobrich L, Eldnasoury S, Gessner A, El-Najjar N
Cancers (Basel). 2021; 13(13).
PMID: 34206772
PMC: 8269327.
DOI: 10.3390/cancers13133193.
Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.
McCusker P, Rohr C, Chan J
PLoS Negl Trop Dis. 2021; 15(3):e0009200.
PMID: 33657133
PMC: 7959349.
DOI: 10.1371/journal.pntd.0009200.
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?.
Dziwornu G, Attram H, Gachuhi S, Chibale K
RSC Med Chem. 2021; 11(4):455-490.
PMID: 33479649
PMC: 7593896.
DOI: 10.1039/d0md00062k.
Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM by PZQ, enhanced Ca influx, spastic paralysis, and tegumental disrupture-the deadly cascade in parasitic schistosomes, other trematodes, and cestodes.
Harder A
Parasitol Res. 2020; 119(8):2371-2382.
PMID: 32607709
PMC: 7366562.
DOI: 10.1007/s00436-020-06763-8.
A Review of Nanotechnology for Targeted Anti-schistosomal Therapy.
Adekiya T, Kondiah P, Choonara Y, Kumar P, Pillay V
Front Bioeng Biotechnol. 2020; 8:32.
PMID: 32083071
PMC: 7005470.
DOI: 10.3389/fbioe.2020.00032.
The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.
Park S, Marchant J
Trends Parasitol. 2019; 36(2):182-194.
PMID: 31787521
PMC: 6937385.
DOI: 10.1016/j.pt.2019.11.002.
The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel.
Park S, Gunaratne G, Chulkov E, Moehring F, McCusker P, Dosa P
J Biol Chem. 2019; 294(49):18873-18880.
PMID: 31653697
PMC: 6901322.
DOI: 10.1074/jbc.AC119.011093.
Anti-schistosomal action of the calcium channel agonist FPL-64176.
McCusker P, Chan J
Int J Parasitol Drugs Drug Resist. 2019; 11:30-38.
PMID: 31561039
PMC: 6796685.
DOI: 10.1016/j.ijpddr.2019.08.006.
Effect of Phenotypic Screening of Extracts and Fractions of Leaf and Stem Bark on Immature and Adult Stages of .
Kyere-Davies G, Agyare C, Boakye Y, Suzuki B, Caffrey C
J Parasitol Res. 2018; 2018:9431467.
PMID: 29977614
PMC: 6011076.
DOI: 10.1155/2018/9431467.
Comparative Characterization of Four Calcium-Binding EF Hand Proteins from .
Emmanoch P, Kosa N, Vichasri-Grams S, Tesana S, Grams R, Geadkaew-Krenc A
Korean J Parasitol. 2018; 56(1):81-86.
PMID: 29529855
PMC: 5858670.
DOI: 10.3347/kjp.2018.56.1.81.
Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
Xiao S, Sun J, Chen M
Infect Dis Poverty. 2018; 7(1):9.
PMID: 29409536
PMC: 5801800.
DOI: 10.1186/s40249-018-0391-x.
Molecular modeling and infrared and Raman spectroscopy of the crystal structure of the chiral antiparasitic drug Praziquantel.
Borrego-Sanchez A, Hernandez-Laguna A, Sainz-Diaz C
J Mol Model. 2017; 23(4):106.
PMID: 28275906
DOI: 10.1007/s00894-017-3266-3.